Related Stories
Progress
For Sopharma AD this effort is another contribution to an excellent corporate governance file.
| Financial structure | |||
|---|---|---|---|
| BGN '000 | 31.12.2021 | 31.12.2020 | 31.12.2019 |
| Total debt capital | 330,622 | 425,329 | 414,032 |
| Loans from banks | 269,766 | 321,020 | 348,391 |
| Leasing and factoring obligations | 60,856 | 104,309 | 65,641 |
| Cash and cash equivalents | 37,717 | 25,293 | 27,362 |
| Net debt | 292,905 | 400,190 | 386,670 |
| Equity attributable to equity holders of the parent | 646,975 | 553,269 | 556,431 |
| Non-controlling interest | 11,893 | 13,326 | 19,341 |
| Total equity | 658,868 | 566,595 | 575,772 |
| Net debt/Total equity | 44% | 71% | 67% |
| Net debt/EBITDA | 2,51 | 4,33 | 3,72 |